Experimental stem cell treatment tested during heart bypass surgery
Disease control
Not yet recruiting
This study is testing whether a stem cell treatment called ADR-002K can help people with heart failure who are having coronary artery bypass surgery. The treatment involves applying stem cells directly to the heart during the surgery. Researchers will follow 50 patients for two y…
Phase: PHASE2 • Sponsor: Rohto Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC